Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H L Bock

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Parasitology Research|January 1, 1989
Antithrombin III substitution affects survival rate in a murine malaria modelR Clemens, H L Bock, B Enders, et al.
The Clinical Investigator|January 1, 1993
Halofantrine: a new substance for treatment of multidrug-resistant malariaH D Nothdurft, R Clemens, H L Bock, et al.
Asian Pacific Journal of Allergy and Immunology|November 9, 2001
Immunogenicity and adverse effects of live attenuated varicella vaccine (Oka-strain) in children with chronic liver diseaseC Nithichaiyo, V Chongsrisawat, Y Hutagalung, et al.
Zentralblatt Fur Hygiene Und Umweltmedizin = International Journal of Hygiene and Environmental Medicine|November 1, 1989
[Is there a paraspecific effect of influenza vaccination?]H Maiwald, H L Bock, T Schleich, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1992
Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccinationG Hess, V Hingst, J Cseke, et al.
Vaccine|March 1, 1997
Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccineH Maiwald, W Jilg, H L Bock, et al.
Infection|May 1, 1992
Hepatitis B and C in heterosexual patients with various sexually transmitted diseasesE E Petersen, R Clemens, H L Bock, et al.
Lancet (London, England)|April 17, 1993
Anti-HAV seroprevalence in German travellers and hepatitis A vaccination in immune subjectsU Bienzle, H L Bock, W Meister, et al.
Arzneimittel-Forschung|July 1, 1987
Virus safety of a pasteurized antithrombin III concentrate. Preclinical and clinical dataR Clemens, E Weidmann, W Merkle, et al.
Singapore Medical Journal|March 31, 2006
Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adultsS H Chan, P T N Tan, H H Han, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Parasitology Research|January 1, 1989
Antithrombin III substitution affects survival rate in a murine malaria modelR Clemens, H L Bock, B Enders, et al.
The Clinical Investigator|January 1, 1993
Halofantrine: a new substance for treatment of multidrug-resistant malariaH D Nothdurft, R Clemens, H L Bock, et al.
Asian Pacific Journal of Allergy and Immunology|November 9, 2001
Immunogenicity and adverse effects of live attenuated varicella vaccine (Oka-strain) in children with chronic liver diseaseC Nithichaiyo, V Chongsrisawat, Y Hutagalung, et al.
Zentralblatt Fur Hygiene Und Umweltmedizin = International Journal of Hygiene and Environmental Medicine|November 1, 1989
[Is there a paraspecific effect of influenza vaccination?]H Maiwald, H L Bock, T Schleich, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1992
Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccinationG Hess, V Hingst, J Cseke, et al.
Vaccine|March 1, 1997
Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccineH Maiwald, W Jilg, H L Bock, et al.
Infection|May 1, 1992
Hepatitis B and C in heterosexual patients with various sexually transmitted diseasesE E Petersen, R Clemens, H L Bock, et al.
Lancet (London, England)|April 17, 1993
Anti-HAV seroprevalence in German travellers and hepatitis A vaccination in immune subjectsU Bienzle, H L Bock, W Meister, et al.
Arzneimittel-Forschung|July 1, 1987
Virus safety of a pasteurized antithrombin III concentrate. Preclinical and clinical dataR Clemens, E Weidmann, W Merkle, et al.
Singapore Medical Journal|March 31, 2006
Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adultsS H Chan, P T N Tan, H H Han, et al.
Pageof 7